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The carboxyl terminus of the bacteriophage T4 DNA polymerase
is required for holoenzyme complex formation
A NTHONY J. BERDIS, PATRICE SOUMILLION,

AND

STEPHEN J. BENKOVIC

ABSTRACT
To further elucidate the mechanism and
dynamics of bacteriophage T4 holoenzyme formation, a mutant polymerase in which the last six carboxyl-terminal amino
acids are deleted, was constructed, overexpressed, and purified to homogeneity. The mutant polymerase, designated DC6
exo2, is identical to wild-type exo2 polymerase with respect to
kcat, kpol, and dissociation constants for nucleotide and DNA
substrate. However, unlike wild-type exo2 polymerase, the
DC6 exo2 polymerase is unable to interact with the 45 protein
to form the stable holoenzyme. A synthetic polypeptide corresponding to the carboxyl terminus of the wild-type exo2
polymerase was tested as an in vitro inhibitor of bacteriophage
T4 DNA replication. Surprisingly, the peptide does not directly
inhibit holoenzyme complex formation by disrupting the
interaction of the polymerase with the 45 protein. On the
contrary, the peptide appears to disrupt the interaction of the
44y62 protein with the 45 protein, suggesting that the 44y62
protein and the polymerase use the same site on the 45 protein
for functional interactions. Data presented are discussed in
terms of a model correlating the functionality of the carboxyl
terminus of the polymerase for productive interactions with
the 45 protein as well as in terms of the 45 protein concomitantly interacting with the 44y62 protein and polymerase.
The bacteriophage T4 holoenzyme is a complex of the T4 DNA
polymerase and 45 protein, assembled onto duplex DNA in an
ATP-dependent process by the 44y62 protein (reviewed in
refs. 1 and 2). Although intimately involved in the assembly
process, the 44y62 protein does not remain part of the holoenzyme complex but instead acts catalytically (3, 4). The role
of the 45 protein is to act as a sliding clamp that tethers the
polymerase to the DNA primerytemplate, increasing the processivity of the polymerase. The processivity factor of the T4
system is believed to encircle DNA in a manner identical to
that of the b subunit (5) and proliferating cell nuclear antigen
(6), based upon preliminary x-ray crystallographic studies of
the 45 protein (J. Kuriyan, personal communication) as well as
functional similarities among the three clamps. While the
dynamics of clamp opening andyor closing are still speculative,
it is believed that the 44y62 protein clamp loader opens and
closes the 45 protein clamp by an energy transduction mechanism that closely couples the energy of ATP hydrolysis to
some physical force (A.J.B. and S.J.B., unpublished data).
Once loaded onto DNA, the 45 protein and polymerase form
a tightly associated complex that is highly stable on duplex
DNA (8). Of paramount interest and importance is the mechanism and molecular contacts describing how the sliding clamp
and polymerase interact to form the stable holoenzyme.
Studies of processive DNA replication from various systems
have revealed the qualitative importance of the carboxylterminus of the polymerase in the functional interaction with
its respective accessory protein. Herpes simplex virus holoenThe publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked ‘‘advertisement’’ in
accordance with 18 U.S.C. §1734 solely to indicate this fact.

zyme is composed of the DNA polymerase and the UL42
accessory protein. Similar to the T4 system, the accessory
protein is not necessary for polymerase activity but increases
the processivity of the polymerase (9). Residues within the last
160 aa of the polymerase are reported to be critical for the
polymerase interacting with UL42 and are thus necessary for
viral replication (10, 11). Similarly, a pseudorabies polymerase
mutant lacking the 30 carboxyl-terminal amino acids also
possesses polymerase activity but is deficient in interacting
with its processivity factor (12). Finally, a naturally occurring
mutant of the bacteriophage T4 polymerase in which 20% of
the carboxyl-terminus is deleted (B22 Amber mutant) lacks
polymerase activity but still possesses DNA binding and exonuclease activity (13). However, the deletion mutant does not
exhibit processive exonuclease activity in the presence of the
T4 accessory proteins, suggesting that the carboxyl-terminal
domain of the T4 DNA polymerase may also contain residues
responsible for proper interactions with the processivity factor.
Activation of bacteriophage T4 late transcription in vitro is
also mediated by the T4 DNA polymerase accessory proteins,
the mechanism of which is believed to be similar to that of
DNA replication activation (14). In both processes, the 44y62
protein loads the 45 protein onto duplex DNA in an ATPdependent manner. In transcriptional activation, however, the
interaction of the 45 protein with the RNA polymerase is
mediated by the T4-encoded 33 protein (14), which apparently
contacts both the 45 protein and RNA polymerase (15).
Further studies by the Geidushek group indicated that the
carboxyl terminus of the 33 protein is necessary for proper
interactions with the 45 protein but not with the RNA polymerase (16). Not surprisingly, the carboxyl terminus of the 33
protein and the T4 DNA polymerase are very similar, especially the last 6 aa (Fig. 1). Most likely, the carboxyl-terminal
portion of both proteins play a pivotal role in the physical
interaction with the 45 protein, presumably by similar mechanisms.
Based upon these observations, the identity of molecular
contacts between the 45 protein and DNA polymerase was
addressed by kinetic measurements using a carboxyl terminal
deletion mutant of the T4 exo2 polymerase. Although the
mutant polymerase displays mechanistic and kinetic properties
identical to that of wild-type T4 exo2 polymerase, the mutant
enzyme does not interact with the 45 protein to form the
holoenzyme. A peptide corresponding to the carboxylterminus of the polymerase inhibits the interaction of the 45
protein with the 44y62 clamp loading protein, suggesting that
the 45 protein uses a common face to interact with both the
44y62 protein and polymerase.

MATERIALS AND METHODS
Materials. [g-32P]ATP, [a-32P]dATP, and [a-32P]dCTP
were purchased from New England Nuclear. Unlabeled
dNTPs (ultrapure) were obtained from Pharmacia. ATP,
phosphoenol pyruvate, MgCl2, Mg(OAc)2, and all buffers were
from Sigma. NADH was from Boehringer Mannheim. Syn-
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FIG. 1. Carboxyl terminal alignment of the bacteriophage T4 DNA
polymerase (gp43) and the bacteriophage T4 RNA polymerase binding protein (gp33). Amino acid sequence of the polypeptide used for
inhibition studies is also shown.

thetic polypeptides were the generous gift of Michael Moore
of SmithKline Beecham. All restriction and DNA-modifying
enzymes used during molecular cloning procedures were from
New England Biolabs, Promega, United States Biochemical, or
Boehringer Mannheim. All other materials were obtained
from commercial sources and were of the highest available
quality. Lactate dehydrogenase and pyruvate kinase were from
Sigma. These enzymes were dialyzed against 25 mM Tris (pH
7.5) and stored in 20% glycerol at 2208C.
DNA Substrates. All oligonucleotides, including those containing biotin derivatives, were synthesized by Operon Technologies (Alameda, CA) and purified as previously described
by Capson et al. (17). Duplex DNA containing biotin derivatives (Bio-34y62y36-mer) was prepared as previously described (3, 4), while 13y20-mer and 20y27-mer duplex DNA
substrates were prepared by the protocol described by Kuchta
et al. (18). All duplex DNA was then purified as described by
Capson et al. (17) and quantitated as described by Kuchta et al.
(18).
Enzymes. The T4 exonuclease-deficient polymerase D129A
(Asp-219 3 Ala mutation) was purified as previously described (19). The T4 accessory proteins 44y62 and 45 were
purified from overproducing strains obtained from William
Konigsberg (Yale University). The concentration of the 44y62
and 45 proteins are reported as units of 4:1 complex and
trimer, respectively, in agreement with the stoichiometry reported by Jarvis et al. (20).
Mutant Polymerase Construction and Purification. The
Escherichia coli strain MV1190 (supE) used for the expression
of the T4 polymerase mutant was a generous gift from Nancy
Nossal (National Institutes of Health). The plasmid containing
the T4 wild-type exo2 polymerase gene, pTC1203, was previously constructed by Frey et al. (19). Removal of the six
carboxyl terminal residues of the T4 exo2 polymerase took
advantage of a HindIII site located nine codons before the
termination signal in pTC1203. The plasmid was constructed
by ligation of three fragments isolated as follows. A 265-bp
fragment was isolated by agarose gel electrophoresis after
restriction digest of pTC1203 with HindIII and BstXI. Similarly, a 5280-bp fragment was obtained after restriction with
PstI and BstXI. The third fragment is a small, synthetic
12y20-mer that introduces a termination code after Ser-892.
The synthesized oligonucleotides are 59-AGCTAGCTGATAGGGGTGCA and 59-CCCCTATCAGCT. After purification and annealing, the 12y20-mer was 59-labeled by T4
polynucleotide kinase. The three purified fragments were then
ligated to yield the expected plasmid vector. After transformation in MV1190, the clone expressing the deletion mutant
was identified by the introduction of a new NheI site concomitant with the removal of the unique PstI site in the new
plasmid. The T4 DC6 exo2 polymerase was purified as previously described for wild-type exo2 polymerase (20).
Methods. All assays measuring ATP hydrolysis by the 44y62
protein were as previously described (4). Assays for the
measurement of holoenzyme complex formation were as
described by Kaboord and Benkovic (3) and by Berdis and
Benkovic (4). The amount of complex formation is equivalent
to the amount of fully elongated product (62-mer; ref. 3).

All rapid quench experiments were performed at 208C on
the instrument described by Johnson (21). The assay buffer
used in all kinetic studies consisted of 25 mM Tris-OAc (pH
7.5), 150 mM KOAc, and 10 mM 2-mercaptoethanol. Reactions were quenched into EDTA (0.5 M; pH 7.4) and diluted
1:1 with sequencing gel load buffer (22). Polymerization
reactions were monitored by analysis of the products on 16 or
20% sequencing gels as described by Mizrahi et al. (23). Gel
images were obtained with a Molecular Dynamics
PhosphorImager. Product formation was quantitated by measuring the ratio of radiolabeled extended and nonextended
primer. The ratios of product formation are corrected for
substrate in the absence of polymerase (zero point). Corrected
ratios are then multiplied by the concentration of primery
template used in each assay to yield total product. All concentration are listed as final solution concentrations.
Determination of the equilibrium dissociation constant, KD,
for the 13y20-mer. T4 DC exo2 polymerase (75 nM) was
incubated with 13y20-mer (12.5–200 nM) in assay buffer
containing EDTA (100 mM) and mixed with dATP (50 mM)
containing Mg-acetate (10 mM) in assay buffer. The reactions
were quenched with EDTA (100 mM) at variable times (5–500
ms). Polymerization products were analyzed as described
above.
Determination of the equilibrium dissociation constant, KD,
for dATP. DC6 exo2 polymerase (75 nM) was incubated with
13y20-mer (500 nM) in assay buffer containing EDTA (100
mM) and mixed with dATP (1–50 mM) containing Mg-acetate
(10 mM) in assay buffer. The reactions were quenched with
EDTA (100 mM) at variable times (5–1000 ms), and the
products were analyzed as described above.
Method for measuring T4–DNA dissociation rate constants.
The 13y20-mer DNA substrate (200 nM) and either 100 nM T4
exo2 polymerase or 100 nM DC6 exo2 polymerase were
preincubated in one syringe and then mixed with an equal
volume of single-stranded DNA (2 mgyml). The mixture was
allowed to incubate for times ranging from 5 ms to 20 s, and
any polymerase–DNA complex was chased to product by the
addition of Mg-acetate (10 mM) and dATP (20 mM) with a
constant reaction time of 50 ms. Reactions were quenched by
the addition of 100 mM EDTA after the 50-ms reaction time.
The production of 14y20-mer followed a single exponential
decay from which the observed rate constant was determined.

RESULTS AND DISCUSSION
The bacteriophage T4 DNA core holoenzyme is composed
solely of the DNA polymerase and the 45 protein (3, 4). To
establish firmly the requirements for productive interactions of
the polymerase with the sliding clamp, a mutant T4 DNA
polymerase lacking the last 6 aa from the carboxyl terminus
was constructed, overexpressed, and purified to homogeneity.
To address the role these 6 aa play in interacting with the 45
protein while forming the holoenzyme, it is necessary first to
establish that the mutant polymerase possesses the same
intrinsic kinetic and mechanistic properties of the wild-type
exo2 polymerase. These properties include binding affinity for
DNA primerytemplate and correct nucleotide as well as the
rate of polymerization utilizing defined primerytemplates. The
ability of the mutant polymerase to functionally interact with
the 45 protein can then be unambiguously demonstrated by the
established protocols for measuring holoenzyme complex formation, and definitive structure–function relationships can be
derived for the process and dynamics of holoenzyme formation.
Kinetic Characterization of the DC6 exo2 T4 Polymerase.
Pre-steady-state and steady-state kinetics of first nucleotide
incorporation by the DC6 exo2 polymerase were examined and
compared with wild-type exo2 polymerase. In these experiments, the enzyme is provided with only the next nucleotide for

12824

incorporation (dATP) such that the 13y20-mer substrate is
converted to 14y20-mer product. The reaction was performed
by mixing a solution containing either 75 or 100 nM T4 DC6
exo2 polymerase and 500 nM 59-labeled 13y20-mer in reaction
buffer with an equal volume of a solution containing 10 mM
Mg-acetate and 50 mM dATP in the same reaction buffer. The
reaction was then terminated at various times by the addition
of 500 mM EDTA. The preequilibration of the polymerase and
DNA results in a biphasic reaction profile characterized by a
rapid initial phase followed by a second, slower phase (data not
shown). The burst corresponds to the conversion of all productive enzyme–DNA complexes formed during preequilibration to product, while the steady-state phase represents a slow
step following chemistry that involves product release and
subsequent turnover of remaining substrate. The burst amplitudes obtained in both cases were equal to the amount of
enzyme added (75 and 100 nM, respectively). Both the pre- and
steady-state rate constants for the DC6 exo- polymerase (300
s21 and 2–3 s21, respectively) are comparable to those obtained
for the wild-type exo2 polymerase [400 s21 and 3–4 s21,
respectively (20)].
The binding affinity of the mutated polymerase for the DNA
primerytemplate was directly assessed by two distinct independent methods. The first measurement was the determination of the equilibrium dissociation constant (KD) of the
13y20-mer from enzyme. In these experiments, the polymerization reaction was monitored using a constant amount of
DC6 exo2 polymerase (75 nM) and variable amounts of
13y20-mer (12.5–200 nM). The preincubated enzyme–DNA
solution was then mixed versus a solution containing Mgacetate (10 mM) and dATP (50 mM) and quenched at variable
times with 100 mM EDTA. The observed pre-steady-state
burst of single nucleotide incorporation is consistent with rapid
elongation of the DC6 exo2:13y20-mer complex, and the
amplitude of the burst is a measure of the level of this complex.
For each DNA concentration, the burst amplitude was determined by fitting the corresponding data to an equation describing an initial burst followed by a steady state (data not
shown). The burst amplitudes obtained from each time course
were fit to the quadratic equation [DC6 exo2z13y20-mer] 5
0.5(KD 1 [DC6 exo2] 1 [13y20-mer] 2 0.25(KD) 1 [DC6 exo2]
1 13y20-mer)2 2 [DC6 exo2z13y20-mer]1/2 to yield KD 5 10 6
1 nM. This value is comparable to the values of 70 6 7 nM and
40 6 4 nM obtained for the wild-type exo1 (17) and exo2
polymerase (20), respectively. The lower KD value indicates
that the DC6 exo2 polymerase binds tighter to DNA primery
template, suggesting that these 6 aa at the carboxyl terminus
might normally hinder binding of the polymerase by itself to
the primerytemplate.
The second method was to measure the rate of dissociation
of 13y20-mer from the polymerase. Duplex DNA was preincubated with enzyme and mixed with an enzyme trap (2 mg of
single-stranded DNA per ml) for varying incubation times
followed by the immediate addition of Mg-acetate and dATP.
The reaction solution was quenched with EDTA to a final
concentration of 100 mM after a 50-ms reaction time. The
amount of 14y20-mer formed was determined by sequencing
gel electrophoresis providing data described by a decreasing
single exponential at a rate of 5 6 1 s21 (data not shown). This
value represents the rate constant for dissociation of the
13y20-mer from the DC6 exo2 polymerase and agrees very well
with the value of 3 s21 obtained for wild-type exo1 polymerase
(17). Collectively, the data indicate that the DC6 exo2 polymerase binds to duplex DNA as tightly as either wild-type exo2
or exo1 polymerase. Thus, deletion of the 6 aa from the
carboxyl-terminus of the polymerase does not affect its intrinsic binding capabilities.
To verify that the mutant polymerase did not have an altered
binding affinity for nucleotide substrate, the equilibrium dissociation constant (KD) of the first nucleotide to be incorpo-

rated was measured. Constant amounts of enzyme (75 nM)
and DNA (500 nM) were mixed with variable quantities of
dATP (1–50 mM) in the presence of 10 mM Mg-acetate and
quenched at various times by the addition of 100 mM EDTA.
Each time course was biphasic, and the first order rate
constants from each time course were determined by computer fit to the equation describing an initial burst followed by
a steady state (data not shown). These rate constants were then
fit to the hyperbolic equation kobsd 5 kpol[dATP]y([dATP] 1
KD), yielding values of 8 6 3 mM for KD(dATP) and 300 6 40 s21
for kpol. These values compare well to the values of 20 mM and
400 s21 obtained for wild-type exo1 T4 polymerase (17) and 10
mM and 400 s21 for wild-type exo2 T4 polymerase (20). These
data further confirm that the deletion mutant is identical
kinetically to wild-type exo2 polymerase. Thus, it is reasonable
to presume that any negative effect on holoenzyme complex
formation can clearly be attributed solely to the absence of the
6 aa.
The Carboxyl Terminus of the T4 Polymerase Is Required
for Holoenzyme Complex Formation. The formation of holoenzyme complex using the DC6 exo2 polymerase was examined using a defined primerytemplate system and directly
compared with the ability of the wild-type exo2 polymerase to
form the holoenzyme complex. The initial assay measured the
decrease in the rate of ATP hydrolysis by the 44y62 protein
upon formation of the holoenzyme complex as previously
described (4). Normally, the ATPase activity of the 44y62
protein is synergistically activated in the presence of stoichiometric quantities of 45 protein and Bio-34y62y36-mer DNA
substrate to yield a steady-state rate of ATP hydrolysis of '200
nMys (Fig. 2A). However, upon the addition of a stoichiometric quantity of T4 exo2 polymerase, the ATPase activity of the
44y62 protein decreases to a rate of '20 nMys. The decrease
in ATP hydrolysis by the 44y62 protein under these conditions
is indicative of holoenzyme complex formation (4). The identical assay using a stoichiometric quantity of DC6 exo2 polymerase instead of wild-type exo2 polymerase showed no
decrease in the ATPase activity of the 44y62 protein (Fig. 2 A),
suggesting a lack of holoenzyme complex formation. Furthermore, there is no decrease in the ATPase activity of the 44y62
protein when a 2-fold excess of DC6 exo2 polymerase (500 nM)
is added (data not shown).
A similar contrasting experiment was performed in which
the steady-state rate of ATP hydrolysis using stoichiometric
quantities of 44y62 protein, 45 protein, and Bio-34y62y36-mer
(in the presence of 1 mM streptavidin) was measured in the
absence of either polymerase (Fig. 2B). Upon the addition of
500 nM DC6 exo2 polymerase, there is no decrease in the rate
of ATP hydrolysis by the 44y62 protein ('220 nMys). When
250 nM T4 exo2 polymerase is added after the DC6 exo2
polymerase, the ATPase activity of the 44y62 is decreased to
20 nMys and is indicative of holoenzyme complex formation.
Thus, DC6 exo2 polymerase does not effectively compete with
wild-type enzyme for the 45 protein underscoring the importance of the 6 aa at the carboxyl terminus for the protein–
protein interaction.
A second method to assess holoenzyme formation involves
using the strand displacement assay previously developed by
Kaboord and Benkovic (3). Processive DNA synthesis by the
holoenzyme complex using the defined Bio-34y62y36-mer
DNA substrate (in the presence of streptavidin) results in
strand displacement of the 36-mer forked strand to produce
fully elongated products (a mixture of 61- and 62-mer). Smaller
products (,44-mer) are generated by polymerase not in
holoenzyme since polymerase alone cannot perform strand
displacement synthesis under the reaction times employed in
this study.
Assembly of the holoenzyme complex was performed using
either wild-type exo2 or DC6 exo2 polymerase in which a
solution of Bio-34y62y36 (500 nM) and streptavidin (1 mM)
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FIG. 3. Holoenzyme formation and processive DNA synthesis
measurements by wild-type exo2 polymerase alone (A), in the presence of accessory proteins (B), or by DC6 exo2 polymerase alone (C)
and in the presence of accessory proteins (D). Assays were performed
as described in text.

FIG. 2. Titration curve for the formation of the bacteriophage T4
holoenzyme complex in which the concentration of 44y62 protein was
maintained at 250 nM, while the concentrations of Bio-34y62y36-mer
and 45 protein were fixed at 250 nM. Streptavidin was maintained at
1 mM, while the ATP concentration was fixed at 1 mM. Before the
addition of either polymerase, the steady-state rate of ATP hydrolysis
was 210 nMys. At the times indicated (arrow), either 250 nM T4 exo2
polymerase or 250 nM DC6 exo2 polymerase was added. (A) The
ATPase activity of the 44y62 protein upon the addition of T4 exo2
polymerase decreased to eventually reach a limiting rate of 20 nMys,
while the ATPase activity upon the addition of DC6 exo2 polymerase
did not decrease, indicating that the mutant polymerase is incapable
of holoenzyme formation. (B) The ATPase activity of the 44y62
protein did not decrease upon the addition of DC6 exo2 polymerase,
but did decrease upon the addition of T4 exo2 polymerase, indicating
the specific interaction of wild-type polymerase with the 45 protein.

was incubated with 44y62 protein and 45 protein (550 nM
each) in the presence of 1 mM ATP for 10 s. This time frame
allows for each DNA molecule to be loaded with a 45 protein.
Either 100 nM T4 exo2 polymerase or 100 nM DCexo2
polymerase was then added as well as 10 mM dCTP (the first
nucleotide to be incorporated). After '5 s, the remaining
dNTPs (10 mM each) and single-stranded DNA (to trap free
polymerase) were added to initiate DNA synthesis by any
assembled holoenzyme complexes. The reaction was manually
quenched 10 s after the addition of dNTPs and single-stranded
DNA trap by the addition of 1 M HCl.
Production of 62-mer (Fig. 3B) indicates that holoenzyme
complex is formed using wild-type exo2 polymerase, consistent with previous measurements (3, 4). The DC6 exo2 polymerase does not form a productive holoenzyme complex, since
there are no strand displacement products formed (Fig. 3C)
although the DC6 exo2 polymerase by itself is able to incorporate up to the forked strand (Fig. 3D), as is the case for
wild-type exo2 polymerase alone (Fig. 3A). Collectively, the
lack of holoenzyme assembly by either assay clearly indicates
that the carboxyl terminal portion of the polymerase is directly
responsible for productive interactions with the 45 protein.
Although a crystal structure of the 45 protein has recently been
solved (J. Kuriyan, personal communication), there is no
obvious structural feature present on the 45 protein to account
for its interaction with this 6-aa segment.

Effect of Synthetic Peptide on Holoenzyme Complex Formation. A peptide corresponding to the carboxyl-terminus of
the T4 exo2 polymerase (Fig. 1) was tested as an inhibitor of
holoenzyme formation. Interaction of the peptide with the 45
protein might disrupt the functional interaction of the 45
protein with the polymerase and be manifest in the ATPase
activity of the 44y62 protein during the process of clamp
loading and ultimately holoenzyme formation. The ATPase
activity of the 44y62 protein then would not diminish in the
presence of peptide, since the 45 protein will be constantly
reloaded onto the DNA (by the ATP-dependent action of the
44y62 protein) and would reflect the inhibition of holoenzyme
formation. Thus, by titrating the ATPase activity with variable
concentrations of peptide, an inhibition constant (equivalent
to KD under these conditions) for the peptide would be
obtained reflecting the binding energy of these 6 aa.
However, it was first necessary to verify that the peptide
would not ‘‘lock’’ the 45 protein on the DNA by forming a
‘‘pseudo-holoenzyme complex’’ that would also result in a
diminished ATPase activity of the 44y62 protein. The ATPase
activity of the 44y62 protein in the presence of stoichiometric
45 protein and duplex DNA (20y27-mer) was measured in the
presence of peptide A. The rate of ATP hydrolysis by the 44y62
protein decreased linearly as a function of increasing peptide
concentrations (0–10 mM), consistent with a simple competitive inhibition model (data not shown). A plot of reciprocal
velocities versus peptide concentration is linear, yielding a Ki
value for peptide A equal to 1.6 6 0.2 mM (data not shown).
This decrease in ATPase activity is specific for the interaction
of the 44y62 protein with the 45 protein, since incremental
additions of either 45 protein or 44y62 protein result in linear
increases in ATP consumption (data not shown). It is highly
unlikely that a pseudo-holoenzyme complex was formed on the
DNA that resulted in a diminished ATPase activity of the
44y62 protein, since the DNA substrate used in this experiment was devoid of any physical barriers that would prevent the
45 protein from translocating off the ends of the DNA. The
most likely explanation for the decrease in ATPase activity is
that peptide A specifically interferes with the 44y62 protein
interacting with the 45 protein, ultimately resulting in a lack of
45 protein being loaded onto the DNA. Furthermore, this
interference implies that the 44y62 protein and polymerase
interact with the same ‘‘face’’ or site of interaction of the 45
protein.
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Strand displacement assays were then performed to test if
peptide A can inhibit holoenzyme complex formation by
disrupting the interaction of the 45 protein with the wild-type
exo2 polymerase. These assays were performed as previously
described except that varying concentrations of peptide A
(0–10 mM) were preincubated with the accessory proteins and
DNA in the presence of ATP before the addition of wild-type
T4 exo2 polymerase. As depicted in Fig. 4, holoenzyme
complex is formed even at the highest concentration of peptide
A (10 mM), as judged by the accumulation of 62-mer product.
However, upon close inspection, the gel also reveals smaller
elongation products at higher peptide concentrations, indicating that not all of the polymerase is present as the holoenzyme.
For example, in the absence of peptide A, there is predominant
accumulation of 62-mer product, while very little accumulation
of products ,44-mer, indicating that all polymerase is present
as holoenzyme. However, using 10 mM peptide A, accumulation of products ,44-mer indicate free polymerase, while
strand displacement products (62-mer) indicate formation of
holoenzyme. While it is difficult to accurately quantitate the
amount of polymerase not in the holoenzyme complex under
these steady-state conditions, the data clearly show a relationship between the concentration of peptide A and inhibition of
holoenzyme complex formation.
The inhibition of the ATPase activity of the 44y62 protein
by peptide A suggests that holoenzyme should not have been
formed using the strand displacement assay, especially at the
higher peptide concentrations (.5 mM), since the 45 protein
is presumably inhibited from being loaded onto the DNA. It is
important to note that the ATPase activity of the 44y62 protein
only reflects the interaction of the 44y62 protein with the 45
protein during the process of loading the 45 protein onto
duplex DNA. While 45 protein is hindered from being loaded
onto the DNA in the presence of peptide A, a fraction of the
45 protein will be loaded onto the primerytemplate under
these steady state conditions. Any 45 protein present on the
DNA must be able to interact with the polymerase to form the
holoenzyme due to the production of strand displacement
products. The lack of substantial inhibition of holoenzyme
formation under these steady-state conditions suggests that the
polymerase–45 protein interaction on DNA is extremely tight.
With the koff 5 0.003 s21 (3) and assuming kon 5 108 M21zs21,
we can estimate the equilibrium binding constant of the 45
protein with polymerase on DNA to be at least 30 pM. This low
value will reflect a combination of complex interactions in-

FIG. 4. Holoenzyme formation and processive DNA synthesis
measurements by wild-type exo2 polymerase in the presence of
varying concentrations of peptide A. (A) No peptide; (B) 1 mM; (C)
5 mM; and (D) 10 mM. Assays were performed as described in text.

volving the polymerase–DNA interaction (KD 5 40 nM), the
polymerase–45 protein interaction, and the intrinsic interactions of the 45 protein with the DNA.
Conclusion. DNA replication is a complex process involving
numerous protein–nucleic acid interactions as well as protein–
protein interactions. We have specifically examined the interaction of the bacteriophage T4 DNA polymerase with its
processivity factor, the 45 protein, to address the dynamics and
the minimal recognition sequence required for holoenzyme
formation. The DC6 exo2 mutant polymerase is kinetically
identical to wild-type exo2 polymerase with respect to binding
constants for primerytemplate and nucleotide substrate as well
as with respect to pre-steady-state and steady-state rates of
nucleotide incorporation. The mutant polymerase is unable to
functionally interact with the 45 protein to form the stable
holoenzyme required for processive DNA synthesis. Thus, the
6 aa at the carboxyl terminus of the polymerase are absolutely
required for interaction(s) with the sliding clamp. A peptide
designed to mimic the carboxyl terminus of the polymerase
inhibits the interaction of the 44y62 protein with the 45
protein. Inhibiting the functional interactions of the 44y62
protein with the 45 protein by the peptide designed to mimic
the polymerase implies that the 44y62 protein and polymerase
interact with the 45 protein at a common site. The shared site
of interaction may have implications with regards to the
chaperone function of the 44y62 protein during holoenzyme
assembly (24).
The use of peptidomimetics as therapeutic agents has recently been employed against herpes simplex virus replication
in vitro (7). Similar to our results, the carboxyl-terminus of the
herpes simplex virus polymerase interacts specifically with the
UL42 accessory protein (the functional equivalent of the
bacteriophage T4 45 protein) to increase the polymerase’s low
degree of processivity (10). Large peptides corresponding to
the carboxyl terminus of the polymerase have been used to
disrupt the interaction of the polymerase with UL42, thus
effectively inhibiting processive DNA synthesis by the herpes
simplex holoenzyme in vitro. However, a high concentration of
peptide (100 mM) was used to inhibit all processive DNA
synthesis, making its effectiveness in vivo speculative. Nevertheless, that small peptide fragments can specifically disrupt
the interactions between two large proteins involved in an
essential and complex biological process such as DNA replication is encouraging for further developments of peptides as
therapeutic agents.
One major complication in disrupting the protein–protein
interactions involved in DNA replication is that the peptide
used in our studies most likely does not bind to DNA. Thus, the
peptide can only intercept the accessory proteins before
binding to DNA. As a result, there is very little chance of
disrupting the interaction of the polymerase with its processivity factor once the functional holoenzyme is assembled on
DNA. A more effective approach to inhibiting biological
processes that utilize nucleic acids would be to prevent the
association of the two proteins before complex formation by
linking the peptidomimetic to another molecule (possibly
another protein) that is also capable of tightly binding nucleic
acid. This method would first provide a more structurally
related analog of the protein complex to be inhibited (protein–
DNA complex). Secondly, this approach would also improve
inhibition by removing kinetic barriers imposed by a threedimensional search (peptide free in solution) as opposed to a
two-dimensional search (inhibition complex translocatingy
bound to DNA).
This work supported in part by a National Institutes of Health
Fellowship GM 16704 (A.J.B.) and a U.S. Public Health Service Grant
GM 13306 (S.J.B.). We deeply thank Dr. Michael Moore of SmithKline Beecham for the generous gift of the polypeptides used in this
study.

12827

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.

Nossal, N. G. (1992) FASEB J. 6, 871–878.
Young, M. C., Reddy, M. K. & von Hippel, P. H. (1992) Biochemistry 31, 8675–8690.
Kaboord, B. F. & Benkovic, S. J. (1995) Curr. Biol. 5, 149–157.
Berdis, A. J. & Benkovic, S. J. (1996) Biochemistry 35, 9253–9265.
Krishna, T. S. R., Kong, X.-P., Gary, S., Burgers, P. M. &
Kuriyan, J. (1994) Cell 79, 1233–1243.
Kong, X.-P., Onrust, R., O’Donnell, M. & Kuriyan, J. (1992) Cell
69, 425–437.
Digard, P., Williams, K. P., Hensley, P., Brooks, I. S., Dahl, C. E.
& Coen, D. M. (1995) Proc. Natl. Acad. Sci. USA 92, 1456–1460.
Kaboord, B. F. & Benkovic, S. J. (1993) Proc. Natl. Acad. Sci.
USA 90, 10881–10885.
Hernandez, T. R. & Lehman, I. R. (1990) J. Biol. Chem. 265,
11227–11232.
Digard, P., Bebrin, W., Weisshart, K. & Coen, D. M. (1993)
J. Virol. 67, 1159–1168.
Stow, N. (1993) Nucleic Acids Res. 21, 87–92.
Berthomme, H., Monahan, S. J., Parris, D. S., Jacquemont, B. &
Epstein, A. L. (1995) J. Virol. 69, 2811–2818.
Venkatesan, M. & Nossal, N. G. (1982) J. Biol. Chem. 257,
12435–12443.
Herendeen, D. R., Kassavetis, G. A., Barry, J., Alberts, B. M. &

15.
16.
17.

18.
19.
20.
21.
22.

23.
24.

Geidushek, E. P. (1989) Science 245, 952–958.
Tinker, R. L., Sanders, G. M., Severinov, K., Kassavetis, G. A. &
Geidushek, E. P. (1995) J. Biol. Chem. 270, 15899–15907.
Winkelman, J. W., Kassavetis, G. A. & Geidushek, E. P. (1994)
J. Bacteriol. 176, 1164–1171.
Capson, T. L., Peliska, J. A., Kaboord, B. F., Frey, M. W., Lively,
C., Dahlberg, M. & Benkovic, S. J. (1992) Biochemistry 31,
10984–10994.
Kuchta, R. D., Mizrahi, V., Benkovic, P. A., Johnson, K. A. &
Benkovic, S. J. (1987) Biochemistry 26, 8410–8417.
Frey, M. W., Nossal, N. G., Capson, T. L. & Benkovic, S. J.
(1993) Proc. Natl. Acad. Sci. USA 90, 2579–2583.
Jarvis, T. C., Paul, L. S. & von Hippel, P. H. (1989) J. Biol. Chem.
264, 12709–12716.
Johnson, K. A. (1986) Methods Enzymol. 134, 677–705.
Maniatis, T., Fritsch, E. F. & Sambrook, J. (1982) Molecular
Cloning: A Laboratory Manual (Cold Spring Harbor Lab. Press,
Plainview, NY).
Mizrahi, V., Benkovic, P. A. & Benkovic, S. J. (1986) Proc. Natl.
Acad. Sci. USA 83, 5769–5773.
Kaboord, B. F. & Benkovic, S. J. (1996) Biochemistry 35, 1084–
1092.

Post-print standardized by MSL Academic Endeavors, the imprint of the Michael Schwartz Library at Cleveland State University, 2017.

